PHARMAVIT ApS: Financial statements 2022
CVR: 29316775
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
PHARMAVIT ApS (CVR 29316775) has filed annual accounts for 2022. In 2022, the company reported a gross profit of EUR 1,154,791 and a net result of EUR 707,851 compared with EUR 508,636 the year before. That is an increase of 29.9% compared with the year before. Equity in the 2022 report amounted to EUR 2,639,713. The solvency ratio was 51.6%.
- Gross Profit
- EUR 1,154,791
- Profit/Loss
- EUR 707,851
- Equity
- EUR 2,639,713
- Total Assets
- EUR 5,115,725
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | 1.2 mio. EUR | 708 t. EUR | 2.6 mio. EUR | 0 |
| 2021 | - | 889 t. EUR | 509 t. EUR | 1.9 mio. EUR | 1 |
| 2020 | - | 766 t. EUR | 500 t. EUR | 1.4 mio. EUR | 1 |
| 2019 | - | 464 t. EUR | 126 t. EUR | 924 t. EUR | - |
| 2018 | - | 320 t. EUR | 34 t. EUR | 797 t. EUR | - |
Keep an eye on PHARMAVIT ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
PHARMAVIT ApS has published its annual report for 2021. Gross profit came to DKK 889,298, and the net result was DKK 508,636.
About PHARMAVIT ApS
PHARMAVIT ApS was a Danish company of the type Anpartsselskab based in Helsinge, founded in 2006. The company was registered under the industry Engroshandel med andre fødevarer. The company was previously named ApS KBUS 17 NR. 4736. The company has 1 employee (2018). In 2024, the company reported a gross profit of EUR -11,114 and a net result of EUR -1,886 compared with EUR 3,356,623 the year before. Equity in the 2024 report amounted to EUR 394,450.